Poliovirus: How It Works and Why It Paralyzes

In 1952, more than 21,000 people in the United States were reported with paralytic polio. By 1965 the number had fallen to 61, and the last locally acquired wild case came in 1979. Yet in July 2022 a young, unvaccinated adult in Rockland County, New York, developed paralysis from a poliovirus that had been circulating quietly, and sewage samples later confirmed it was spreading. Understanding why a disease that is nearly gone keeps returning starts with the virus itself: a particle with about 7,500 letters of RNA that has one very specific target.

Educational content, not medical advice. Talk to your doctor before changing any medication, treatment, or routine. Information here reflects current research but every person's situation differs.

To learn how viruses generally enter cells and hijack replication machinery, see How Viruses Work: Infection to Replication. This article focuses on the unusual biology of poliovirus and on why its target, the motor neuron, produces such lasting damage.

What kind of virus is poliovirus?

Poliovirus belongs to the family Picornaviridae (pico means small, plus RNA) and the genus Enterovirus. Its relatives include rhinoviruses, which cause common colds, and coxsackieviruses, which cause hand, foot, and mouth disease. "Entero" refers to the gut: these viruses multiply in the intestinal tract and spread from person to person through stool and contaminated hands, water, or food. The CDC's clinical reference describes poliovirus as an enterovirus with an RNA genome, and notes that it is inactivated by heat, formaldehyde, chlorine, and ultraviolet light (CDC Pink Book, Chapter 18).

The virion (the complete virus particle) is roughly 30 nanometers across, far smaller than any bacterium. Its shell, called a capsid, is an icosahedron (a 20-faced solid) built from copies of four proteins, VP1 through VP4. There is no fatty envelope around it. A naked capsid is much sturdier than the fragile envelope of a virus like influenza, which is part of why poliovirus survives the acid in the stomach and persists in sewage.

The genome is a single strand of positive-sense RNA, about 7,500 nucleotides long. "Positive-sense" means the strand can be read directly by the cell's ribosomes (protein-building machines) the moment it enters the cytoplasm, like a recipe that can be cooked from without first being copied. A small protein called VPg is attached to one end, and a structure called an internal ribosome entry site (IRES) lets ribosomes start reading the genome without the usual cap that host messenger RNAs carry. In effect, the virus uses a side door that the cell's normal quality checks do not guard.

Three serotypes, different fates

Poliovirus comes in three serotypes (types 1, 2, and 3), distinguished by which antibodies neutralize them. Immunity to one type does not give significant protection against the others, which is why every modern vaccine covers all three or, increasingly, targets them in sequence.

Serotype	Wild-virus status	Notes
Type 1 (WPV1)	Still circulating in Afghanistan and Pakistan	The only wild type left
Type 2 (WPV2)	Certified eradicated in 2015	Vaccine-derived type 2 now causes most outbreaks
Type 3 (WPV3)	Declared eradicated on October 24, 2019	Last detected case: northern Nigeria, 2012

The type 3 declaration was made by the Global Commission for the Certification of Poliomyelitis Eradication, as reported by the Global Polio Eradication Initiative (GPEI). Wild type 1 is the only wild serotype that remains.

How does poliovirus get from the mouth to the spinal cord?

The route is fecal-oral. A person swallows virus from contaminated water, food, or hands. It survives the stomach, then replicates in the lining of the throat and small intestine, including clusters of immune tissue in the gut wall. In most people the story ends there, with the immune system clearing the infection.

The gut is both the main factory and the exit door. Infected people shed virus in stool for weeks. The CDC reports that wild poliovirus can persist in stool for up to six weeks, and that a person can spread the virus from just before symptoms begin until about two weeks afterward, including people who never feel sick at all (CDC). In communities with poor sanitation, a single symptom-free child can seed a water supply.

Replication inside a cell

For poliovirus to infect a cell it needs a docking site. The receptor is a protein called CD155 (the poliovirus receptor), found on gut cells and, critically, on motor neurons. When the capsid binds CD155 it changes shape, releases an inner protein, and threads its RNA into the cell.

What happens next follows a pattern shared by many positive-strand RNA viruses:

1. Translation. Host ribosomes read the genome and produce one long polyprotein (a single chain that contains several proteins joined end to end).
2. Cleavage. Viral proteases (enzymes that cut proteins) slice the polyprotein into the capsid proteins and the machinery needed to copy the genome, including an RNA-dependent RNA polymerase.
3. Copying. The polymerase makes a complementary negative-sense strand, then uses it as a template to produce many new positive-sense genomes.
4. Assembly. New genomes are packaged into capsids.
5. Release. Unlike enveloped viruses that bud out of a cell, poliovirus leaves by destroying it. This cell lysis is the direct cause of the tissue damage that makes polio dangerous.

Think of the infected cell as a rented factory. The virus does not bring its own machinery; it commandeers the cell's, repurposes it, and when production is finished it demolishes the building to get the product out. For a gut cell that is replaceable, this is a minor loss. For a motor neuron, it is permanent.

Why do most infections cause no symptoms?

Most poliovirus infections are silent. According to the CDC's Pink Book, about 70% of childhood infections are asymptomatic, about 24% cause a minor illness called abortive poliomyelitis that resolves within a week, 1% to 5% cause nonparalytic aseptic meningitis, and fewer than 1% cause flaccid paralysis (CDC Pink Book). The World Health Organization puts the paralysis figure at about 1 in 200 infections for the dangerous serotypes (WHO fact sheet), and the CDC gives a range of 1 in 200 to 1 in 2,000 depending on virus type.

Outcome of infection	Approximate share (CDC)
No symptoms	About 70%
Minor, flu-like illness	About 24%
Aseptic meningitis (nonparalytic)	1% to 5%
Paralysis	Under 1% (about 1 in 200 to 1 in 2,000, by type)

This lopsided pattern made polio deceptive for decades. A community could have extensive silent circulation while only a handful of paralytic cases became visible. It also explains a counterintuitive feature of modern eradication: for every child paralyzed, many more are infected and shedding. In the 2022 New York outbreak, the CDC calculated that roughly 1 in 1,900 infections with type 2 poliovirus in an unvaccinated person is expected to cause paralysis (MMWR, August 2022). One paralytic case therefore implies on the order of thousands of undetected infections.

How does the virus reach the nervous system?

In the minority of people who go on to develop neurological disease, the virus enters the bloodstream and then the central nervous system. Exactly how it crosses into the spinal cord is still debated. Transport along nerves that supply the gut and muscles is one proposed route, and direct passage from blood across the barrier that protects the nervous system is another. The incubation period before paralysis begins is generally 7 to 21 days, compared with 3 to 6 days for the nonparalytic forms, according to the CDC.

Why does polio target motor neurons?

Once in the spinal cord, poliovirus preferentially infects the anterior horn motor neurons. These are the large nerve cells whose long fibers (axons) leave the spinal cord and connect directly to skeletal muscle. A motor neuron is like the single wire between a light switch and a lamp: if the wire is cut, flipping the switch accomplishes nothing, no matter how healthy the lamp is.

Because anterior horn cells are lower motor neurons, their destruction produces a recognizable clinical fingerprint:

• Flaccid paralysis. Muscles go limp rather than stiff.
• Loss of tendon reflexes in the affected limbs.
• Muscle wasting within weeks as denervated muscle shrinks from disuse.
• Preserved sensation. Touch and pain pathways run through different cells that the virus largely spares.

Contrast this with an upper motor neuron injury, as in a stroke, where the lower neurons are intact but lose their braking signals from the brain. Muscles then become stiff and reflexes brisk, a pattern called spasticity. The difference matters clinically: flaccid, asymmetric weakness that develops over hours to days in a feverish child is the classic polio presentation.

The pattern of damage is patchy and unpredictable. One leg may be severely affected while the other is untouched, depending on which neurons the virus happened to reach. In bulbar polio, the virus attacks motor nuclei in the brainstem that control swallowing and breathing. The CDC lists death rates among people with paralytic disease of 2% to 5% in children and 15% to 30% in adolescents and adults, rising to 25% to 75% when the brainstem is involved. The WHO summarizes it as 5% to 10% of paralyzed people dying when their breathing muscles are immobilized.

Adult motor neurons do not regenerate once destroyed. Recovery depends on how many neurons were killed outright versus temporarily injured. Even so, paralysis is often lasting: the Pink Book notes it persists at 12 months in about two-thirds of patients. For more on how the nervous system conducts these signals, see How the Nervous System Works.

The iron lung

When the diaphragm and chest muscles failed, patients could not breathe. The iron lung, a sealed metal cylinder that surrounded the body and cyclically lowered the air pressure around the chest, forced the ribs to expand and air to flow in. It was a negative-pressure ventilator, the mirror image of modern ventilators that push air in. For the physiology of breathing itself, see How the Lungs Work: Respiration. Some survivors lived in or alongside these machines for decades.

Two vaccines, two strategies

Two vaccines made the near-elimination of polio possible. They work on the same target but in different ways, and that difference shapes the endgame.

Salk IPV (inactivated polio vaccine)

Jonas Salk's vaccine, licensed in 1955, uses poliovirus grown in culture and chemically inactivated, so it cannot cause disease. It is injected, and it generates strong antibodies in the blood that stop the virus from reaching the nervous system. The CDC reports that at least 90% of recipients are immune to all three types after two doses and at least 99% after three, and that immunity is probably lifelong after a complete series. IPV does not generate as strong a response in the lining of the gut, so vaccinated people can still carry and shed virus in stool after exposure, even though they are protected from paralysis.

Sabin OPV (oral polio vaccine)

The oral vaccine uses live but weakened (attenuated) virus. In the United States, monovalent OPV against types 1 and 2 was licensed in 1961, type 3 in 1962, and trivalent OPV in 1963. Because the weakened virus multiplies in the gut, it trains the immune system where the real virus first arrives, so it blocks transmission more effectively than the injected vaccine. It is also cheap, needs no needles, and can be given by community health workers, which made mass campaigns possible.

The cost of using a live virus is rare, but real. Roughly 1 in 2 to 3 million doses of trivalent OPV caused vaccine-associated paralytic polio (VAPP), according to the CDC. The risk was 7 to 21 times higher after the first dose than after later ones, and about 7,000 times higher in people with certain immune deficiencies. Between 1980 and 1999, the United States reported 162 paralytic cases, about 95% of them vaccine-associated. The last U.S. case of VAPP was in 1999, and the country moved to an all-IPV schedule.

Feature	Salk IPV	Sabin OPV
Virus type	Killed	Live, attenuated
Route	Injection	Oral drops
Blood antibodies	Strong	Strong
Gut immunity	Weaker	Stronger
Stops spread in communities	Less effective	More effective
Cost and logistics	Higher	Lower
VAPP risk	None	Roughly 1 in 2 to 3 million doses
Can revert to a dangerous form	No	Yes (vaccine-derived poliovirus)

For a general explanation of how vaccines teach the immune system, see How Vaccines Actually Work and How Vaccines Train Memory B Cells. Antibodies, the proteins that do the neutralizing, are covered in Antibody Structure.

The vaccine-derived poliovirus problem

The weakened strains in oral vaccine are weakened by a small number of mutations. In a population with enough immunity, the vaccine virus fades out harmlessly. In a population with many unprotected children, it can pass from person to person for months, accumulating mutations until it regains the ability to paralyze. The result is circulating vaccine-derived poliovirus (cVDPV), which causes outbreaks that look the same as those from wild virus.

The New York case shows how this works in a wealthy country. The MMWR report found a type 2 vaccine-derived virus, differing from the Sabin type 2 vaccine strain by 10 nucleotides in the VP1 capsid gene, and concluded that transmission likely began with someone who had received oral vaccine abroad. The patient was unvaccinated and had a normal immune system. Wastewater testing found 21 of 260 samples positive by August 10, 2022, 13 in Rockland County and 8 in neighboring Orange County. Three-dose polio coverage among children under 24 months in Rockland County was 60.3% in August 2022, and in some ZIP codes as low as 37.3%, compared with 92.7% nationally.

The lesson is not that oral vaccine is dangerous. It is that a live-virus vaccine depends on high coverage, and that gaps in coverage anywhere can allow the virus to re-emerge. This is the central tension of the eradication endgame: the tool that best interrupts transmission can, in under-immunized places, create new chains of it.

Why wastewater surveillance matters

Because most infections are silent, paralytic cases are the tip of the iceberg. Public health agencies therefore test sewage. Laboratories concentrate virus from raw wastewater and use a molecular test (reverse transcription PCR) to detect poliovirus RNA, then sequence it to see how it relates to known strains. It works like a city-wide stool sample: a single positive result tells you the virus is moving through a community of thousands, long before a child becomes paralyzed.

In Rockland County, detections ran from up to 25 days before to 41 days after the patient's symptom onset, which means the virus had been moving through the community before the case was recognized. This is why environmental surveillance is now treated as a primary early-warning tool, not a back-up.

The eradication campaign: 1988 to now

In 1988, the World Health Assembly resolved to eradicate polio. The WHO estimates that wild poliovirus was then paralyzing around 350,000 people a year in more than 125 countries. Led by WHO, UNICEF, Rotary International, and the CDC, the Global Polio Eradication Initiative (GPEI) organized mass vaccination days and surveillance for children with sudden limb weakness. WHO reports that cases have fallen by more than 99% since then, and it estimates that eradication will save at least US$ 40 to 50 billion, mostly in low-income countries. Regions have been certified wild-polio-free one by one: the Americas in 1994, the Western Pacific in 2000, Europe in June 2002, South-East Asia on March 27, 2014, and Africa in 2020.

Wild poliovirus type 1 now persists in only two countries, Pakistan and Afghanistan. According to GPEI country updates as of October 14, 2026, the counts were:

Country	WPV1 cases, 2025	WPV1 cases, 2026 (year to date)
Pakistan	31	6
Afghanistan	21	36

Source: GPEI, "Polio this week", data as of October 14, 2026. Counts change as late reports and confirmations arrive.

Circulating vaccine-derived type 2 is now more widespread geographically than wild virus. The same GPEI page lists 2026 cVDPV2 cases, as of the same date, in the Democratic Republic of the Congo (71), Nigeria (36), Somalia (6), Mali (5), and South Sudan (4). The page gives country figures only, not a global total. The WHO also notes that the polio program has been declared a Public Health Emergency of International Concern.

For comparison with other vaccine-preventable diseases and how they behave once vaccination slips, see Measles Virus Explained and Rotavirus Explained. Smallpox remains the one human disease eradicated so far; see Smallpox: The Variola Virus Explained for how that was achieved, and The Jenner Smallpox Vaccination for where vaccination began.

Post-polio syndrome: decades later

Survivors of paralytic polio began reporting a new problem in the 1980s: post-polio syndrome (PPS), with new muscle weakness, pain, and fatigue appearing decades after the original illness. The CDC states that PPS occurs in 25% to 40% of people who had paralytic polio in childhood, typically 15 to 40 years later. It is not a new infection and it is not contagious.

The leading explanation involves the way the nervous system compensates for loss. After acute polio, surviving motor neurons sprout new branches and take over muscle fibers abandoned by dead neurons. A single neuron may end up supporting several times as many fibers as normal. Imagine one power strip running far more appliances than it was designed for. It works, but it is under constant strain, and after many years some of these overextended neurons begin to fail, so muscles that had been working weaken again. PPS is rarely life-threatening, and treatment focuses on managing symptoms and conserving energy.

Why the last steps are the hardest

Eliminating the final cases of a disease is far harder than reducing it by 99%. Several factors combine:

• Remaining reservoirs are in the hardest places. Areas with conflict, displacement, poor sanitation, and limited health-care access are hard to reach with repeated vaccination rounds.
• Vaccine-derived virus. Gaps in coverage anywhere can allow a weakened vaccine strain to evolve into a new threat. That is why the program is working to sequence the use of different vaccines, shifting toward injected vaccine as wild virus is cleared.
• Better detection. More sensitive sewage testing finds virus that would once have gone unseen, which can raise apparent counts even as real paralysis falls.
• Silent spread. Because roughly 99 in 100 infections do not paralyze, transmission can continue undetected through a large number of infections.
• Funding and attention. As a disease vanishes from view in wealthy countries, the political urgency to finish the job can fade.

Stopping vaccination before eradication would let the virus rebound into a world where children are increasingly unprotected. That is the logic behind finishing the job rather than managing polio indefinitely.

What this means

Poliovirus is a case study in how a simple microbe, about 7,500 letters of RNA in a protein shell, can exploit one specific doorway (CD155) to wreck one specific cell type (the motor neuron). Its biology also explains the difficulty of eradication: most infections are silent, shedding is prolonged, and a vaccine that stops transmission best can, under conditions of low coverage, regain enough virulence to cause disease. The numbers show real progress, from 350,000 yearly cases in 1988 to dozens today, and also show how persistent the last chains can be. The path to zero runs through ordinary things: reaching every child, testing every sewer, and keeping coverage high everywhere at once.

FAQs

Q: Can you get polio from the vaccine? A: Not from IPV, the injected inactivated vaccine, which contains no live virus. The oral live vaccine carried a very small risk, roughly 1 case of vaccine-associated paralytic polio per 2 to 3 million doses of trivalent OPV according to the CDC. In under-immunized communities, oral vaccine virus can also evolve into circulating vaccine-derived poliovirus.

Q: Why does polio cause flaccid paralysis rather than spastic paralysis? A: Poliovirus destroys anterior horn lower motor neurons, the cells that directly drive muscle contraction. Without them, muscles go limp and reflexes disappear. Spastic paralysis occurs when upper motor neurons are damaged, leaving the lower neurons intact but without inhibitory control.

Q: Is polio completely eradicated? A: No. Wild poliovirus type 1 still circulates in Pakistan and Afghanistan, with 6 and 36 cases respectively reported for 2026 as of October 14, 2026 per GPEI. Wild types 2 and 3 were certified eradicated in 2015 and 2019, but vaccine-derived strains continue to cause outbreaks in several countries.

Q: How long after infection does paralysis appear? A: According to the CDC, paralysis usually begins 7 to 21 days after infection, compared with 3 to 6 days for nonparalytic illness. The weakness often develops quickly, over hours to a few days, frequently after a fever and other early symptoms.

Q: Why do some people recover and others do not? A: Recovery depends on whether motor neurons were injured or killed. Injured neurons can recover; dead ones cannot be replaced. Surviving neurons can also sprout new connections to rescue orphaned muscle fibers. Even so, the CDC notes that paralysis persists at 12 months in about two-thirds of paralyzed patients.

Q: What does post-polio syndrome involve? A: It involves new weakness, muscle and joint pain, and fatigue that appear 15 to 40 years after the original illness. The CDC says it affects 25% to 40% of people who had paralytic polio in childhood. It is not an active infection and cannot be passed to others.

Q: How was poliovirus detected in New York in 2022? A: After a young adult in Rockland County developed paralysis, investigators tested wastewater. As of August 10, 2022, 21 of 260 samples were positive, 13 in Rockland County and 8 in Orange County, and 20 were genetically linked to the patient's virus. Sequencing identified a type 2 vaccine-derived poliovirus.

Q: How does poliovirus differ from other enteroviruses such as coxsackievirus or EV-D68? A: They share the same family and mostly fecal-oral or respiratory spread, but they differ in receptors and the tissues they target. Poliovirus relies on CD155, which is abundant on motor neurons, making it uniquely destructive to the motor system. A related virus, enterovirus D68, is linked to a rare polio-like paralysis, covered in Enterovirus D68: The Virus Behind AFM.

Sources

• World Health Organization. Poliomyelitis (Polio), fact sheet dated April 2, 2025. who.int/news-room/fact-sheets/detail/poliomyelitis
• Centers for Disease Control and Prevention. About Polio. cdc.gov/polio/about
• Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book), Chapter 18: Poliomyelitis. cdc.gov/pinkbook
• CDC. MMWR, "Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater, New York, June-August 2022." cdc.gov/mmwr/volumes/71/wr/mm7133e2.htm
• Global Polio Eradication Initiative. Polio this week (data as of October 14, 2026). polioeradication.org
• Global Polio Eradication Initiative. Two out of three wild poliovirus strains eradicated. polioeradication.org

---

Read next:

• Enterovirus D68: The Virus Behind AFM
• Shingles & Varicella-Zoster Virus: Deep Dive
• How the Human Immune System Fights Viruses